Literature DB >> 31525125

Validity Evidence for the LittlEARS Early Speech Production Questionnaire: An English-Speaking, Canadian Sample.

Olivia Daub1, Janis Oram Cardy2, Andrew M Johnson3, Marlene P Bagatto2,4.   

Abstract

Purpose This study reports validity evidence for an English translation of the LittlEARS Early Speech Production Questionnaire (LEESPQ). The LEESPQ was designed to support early spoken language outcome monitoring in young children who are deaf/hard of hearing. Methods Data from 90 children with normal hearing, ages 0-18 months, are reported. Parents completed the LEESPQ in addition to a concurrent measure of spoken language development, the Receptive-Expressive Emergent Language Test-Third Edition. Normal hearing status and development were confirmed. Results Traditional scale analyses, in addition to item parameters, are reported. The LEESPQ was highly correlated with the Receptive-Expressive Emergent Language Test-Third Edition (r = .92) and age (r = .90) and had high internal consistency (Ω = 0.92). Common factor analysis revealed 2 underlying factors conceptually mapping onto items measuring vocal and symbolic development. A latent traits model was the best fit to the data, and item difficulty broadly conformed to theoretical expectations. Conclusions The present work demonstrates that the LEESPQ accurately captures early spoken language development in a typically developing group of young children. The LEESPQ holds promise as a clinically feasible, spoken language outcome monitoring tool. Future work to identify differences in performance characteristics between typically developing children and clinical populations is warranted.

Entities:  

Year:  2019        PMID: 31525125     DOI: 10.1044/2019_JSLHR-L-18-0411

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  1 in total

1.  Validation of LittlEARS® Early Speech Production Questionnaire in Arabic-speaking children with normal hearing.

Authors:  Tamer A Mesallam; Medhat Yousef; Ilona Anderson; Yassin Abdelsamad; Sara Alkhamiss; Abdulrahman Alsanosi
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.